Subpages Investors & Media Shares Presentations Share Issue Ownership Structure Corporate Governance Calendar Financial Reports Press Releases Investors & Media Contact Subscribe
Ten largest shareholders as of November 23, 2023
Name Series A shares Series B shares Share capital % Voting rights %
ANNWALL & ROTHSCHILD INVESTMENT AB 453 283 721 351 8.72 29.93
SIX SIS AG, W8IMY 0 1 483 423 11.01 8.45
FJÄRDE AP-FONDEN 0 1 344 000 9.98 7.66
NORTHERN TRUST COMPANY 0 1 007 094 7.48 5.74
AMF AKTIEFOND 0 601 902 4.47 3.43
TREDJE AP-FONDEN 0 601 894 4.47 3.43
UNIONEN 0 532 023 3.95 3.03
SEB AB, LONDON 0 431 429 3.20 2.46
ÅLANDSBANKEN ABP 0 403 245 2.99 2.30
DANGOOR, DAVID 0 367 705 2.73 2.10
Sub-total 453 283 7 494 066 59.00 68.53
Other shareholders 0 5 524 071 41.00 31.47
Total 453 283 13 018 137 100.00 100.00
Source: Euroclear Sweden AB
The total registered share capital of Infant Bacterial Therapeutics AB consists of 453,283 class A shares with 10 votes per share and 13,018,137 class B shares with one vote per share, in total 13,471,420 shares.